Developing vaccines for biodefense and emerging infectious diseases
Official title: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
Funded at Access to Advanced Health Institute · NIH-11041315 · Data updated 2026-11-12
This study is working on new vaccines to help protect people from serious infections that could come from natural outbreaks or intentional releases, and it aims to make sure these vaccines are safe and effective for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Access to Advanced Health Institute NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | September 9, 2019 |
| Project end | October 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $2,815,090 |
| NIH project number | 75N93019C00059-P00012-9999-1 |
| Project ID | NIH-11041315 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals at risk of exposure to emerging infectious diseases or those living in areas prone to outbreaks.
✕Less likely to help
Patients who are not at risk for emerging infectious diseases or those who have contraindications to vaccination may not receive benefit from this research.
What this research studies
This research focuses on creating advanced vaccine candidates to protect against infectious diseases that may arise from natural outbreaks or intentional releases. The approach includes formulating and manufacturing vaccine components, conducting stability tests, and evaluating their effectiveness in animal models. The research also involves ensuring the safety and efficacy of these vaccines through rigorous clinical assessments and regulatory submissions. Patients may benefit from the development of these vaccines as they could provide protection against serious infectious threats.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect patients from emerging infectious diseases and bioterrorism threats.
How similar studies have gone: Previous research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising potential for this approach.
Where this research is happening
-
Access to Advanced Health Institute
Seattle, United States Active
Researchers
- Principal investigator: Casper, Corey — Access to Advanced Health Institute
- Study coordinator: Casper, Corey
Related research
Other NIH-funded projects on the same topics.
-
Developing vaccines for infectious diseases and biodefense
This study is working on developing new vaccines to protect people from infectious diseases that could come from natural outbreaks or intentional releases, and it's testing these vaccines in animals to make sure they're safe and effective before they can be used in humans.
-
Developing a vaccine to prevent Entamoeba histolytica infections
This study is working on a new vaccine to help protect people from a parasite that can cause serious stomach problems, and if it works well, it could be especially helpful for those living in places where these infections are more common.
-
Developing a vaccine to prevent Entamoeba histolytica infections
This study is working on a new nasal vaccine to help protect people from a parasite that causes serious stomach issues, and if it works well in tests, it could offer a new way to prevent these infections in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.